There’s just 1 week left to register for our live broadcast covering essential updates in MASLD/MASH management. Don’t miss these expert insights on diagnosis and treatment! Sign up today: https://ow.ly/UNhz50UabRm #MASLD #MASH #LiverDisease #MedicalEducation
关于我们
ReachMD is a multi-channel producer and distributor of education to healthcare professionals. In addition to offering over 10,000 programs and a personalized user experience, our digital platform includes on-demand content, live broadcasts, and 24/7 radio streaming. The ReachMD Distribution Network is accessible on websites and on the ReachMD, Amazon Alexa, iHeartRadio, TuneIn, iTunes, Stitcher, PlayerFM, and Google Play mobile apps, so that no matter where healthcare professionals are, they can always Be Part of the Knowledge.
- 网站
-
https://www.ReachMD.com
ReachMD的外部链接
- 所属行业
- 广播媒体制作和发布
- 规模
- 201-500 人
- 总部
- Fort Washington,Pennsylvania
- 类型
- 私人持股
- 创立
- 2006
- 领域
- Medical Communications、Continuing Medical Education、Healthcare Agency、Healthcare Communications、Medical News、CME Credits和Specialty News
地点
-
主要
1301 Virginia Dr
Suite 300
US,Pennsylvania,Fort Washington,19034
ReachMD员工
动态
-
Can't attend our satellite symposium at #ESMOASIA24? Tune in to the broadcast instead! Experts will discuss the latest evidence on HER2-targeted therapies for HER2+ advanced solid tumors and explore how molecular profiling can guide treatment decisions. https://ow.ly/QFEB50UgGzy
HER2+ Advanced Solid Tumors: A Fireside Chat on Harnessing Molecular Profiling to Improve Patient Outcomes
reachmd.com
-
Are you ready to test your knowledge of steroidal and nonsteroidal MRAs? Dive into our engaging Q-Challenge quiz designed to help you enhance your expertise and stay ahead in your field. Whether you're looking to sharpen your skills or simply enjoy a challenge, this quiz is the perfect way to elevate your practice. Start the quiz now: https://ow.ly/uHeQ50UgHoc
Discover How Nonsteroidal MRAs Can Enhance Outcomes in CKD and T2D
-
Join us for a comprehensive look at SGLT2 inhibition for CKD and heart failure. Just ONE WEEK left until this upcoming LIVE broadcast where experts will share essential insights: https://ow.ly/TJET50UabvY #SGLT2 #CKD #HF
Refining Strategies for Enhancing Cardiorenal Outcomes with SGLT2 Inhibitors: Optimizing the Cardiometabolic Care Model
reachmd.com
-
Dr. Joseph Goldberg explains the importance of early PTSD screening. Learn about key symptoms like hyperarousal, mood changes, and re-experiencing trauma. Discover why a sensitive, tailored approach is crucial for accurate diagnosis and effective treatment. #PTSD #MentalHealth?
-
How can we integrate molecular profiling into clinical care to drive treatment decisions for patients with HER2+ advanced solid tumors? Join us at #ESMOASIA24 on 12/8 for a LIVE event on effective strategies in HER2+ solid tumor care: https://lnkd.in/esRqJD8j #CME #Oncology
HER2+ Advanced Solid Tumors: A Fireside Chat on Harnessing Molecular Profiling to Improve Patient Outcomes
reachmd.com
-
How can we improve the management of patients with endometriosis? Dr. Lee Shulman sits down with endometriosis patient advocate Ashley Cholast to answer this question. Ashley sheds light on the daily realities of living with endometriosis and highlights the importance of believing patients and acknowledging their experiences as a cornerstone of compassionate care. She explains how offering a possible diagnosis—even if it's preliminary—can empower patients to explore interventions like dietary changes or seek specialists. Discover more powerful conversations between providers and patient advocates on endometriosis care: https://ow.ly/Rvyh50Uch3i #EndoVOICE #Endometriosis #WomensHealth #MedicalEducation?
-
Check out our upcoming live broadcast to hear the latest updates on MASLD/MASH care. We’re covering early identification, risk stratification, and emerging therapies: https://ow.ly/WUU450UabNv #MASLD #MASH #LiverDisease #MedicalEducation
The Changing Paradigm of Treating MASLD/MASH: At the Crossroads of Hepato-Cardiometabolic Care
reachmd.com
-
Not all trauma leads to PTSD. Dr. Joseph Goldberg, Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai, explains what sets PTSD apart and why some people are more vulnerable. #PTSD #MentalHealth #Trauma
-
What are the latest ADA-KDIGO consensus recommendations for treating CKD and/or HF? What role do SGLT2 inhibitors play in treatment? We’re answering these questions and more at this upcoming LIVE broadcast: https://ow.ly/Cmb250Uabp9 #SGLT2 #CKD #HF
Refining Strategies for Enhancing Cardiorenal Outcomes with SGLT2 Inhibitors: Optimizing the Cardiometabolic Care Model
reachmd.com